JP2025503152A5 - - Google Patents

Info

Publication number
JP2025503152A5
JP2025503152A5 JP2024543941A JP2024543941A JP2025503152A5 JP 2025503152 A5 JP2025503152 A5 JP 2025503152A5 JP 2024543941 A JP2024543941 A JP 2024543941A JP 2024543941 A JP2024543941 A JP 2024543941A JP 2025503152 A5 JP2025503152 A5 JP 2025503152A5
Authority
JP
Japan
Application number
JP2024543941A
Other languages
Japanese (ja)
Other versions
JP2025503152A (ja
JPWO2023138696A5 (https=
Filing date
Publication date
Priority claimed from CN202210079582.1A external-priority patent/CN116510021A/zh
Application filed filed Critical
Publication of JP2025503152A publication Critical patent/JP2025503152A/ja
Publication of JP2025503152A5 publication Critical patent/JP2025503152A5/ja
Publication of JPWO2023138696A5 publication Critical patent/JPWO2023138696A5/ja
Pending legal-status Critical Current

Links

JP2024543941A 2022-01-24 2023-02-15 慢性ｂ型肝炎のヌクレオシド（ヌクレオチド）類薬物の治療を有限化する薬物及び方法 Pending JP2025503152A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202210079582.1A CN116510021A (zh) 2022-01-24 2022-01-24 有限化慢性乙肝的核苷（酸）类药物治疗的药物及方法
PCT/CN2023/076223 WO2023138696A1 (zh) 2022-01-24 2023-02-15 有限化慢性乙肝的核苷(酸)类药物治疗的药物及方法

Publications (3)

Publication Number Publication Date
JP2025503152A JP2025503152A (ja) 2025-01-30
JP2025503152A5 true JP2025503152A5 (https=) 2026-02-17
JPWO2023138696A5 JPWO2023138696A5 (https=) 2026-02-17

Family

ID=87347912

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024543941A Pending JP2025503152A (ja) 2022-01-24 2023-02-15 慢性ｂ型肝炎のヌクレオシド（ヌクレオチド）類薬物の治療を有限化する薬物及び方法

Country Status (5)

Country Link
US (1) US20250161335A1 (https=)
EP (1) EP4470564A4 (https=)
JP (1) JP2025503152A (https=)
CN (2) CN116510021A (https=)
WO (1) WO2023138696A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025087290A1 (zh) * 2023-10-27 2025-05-01 苏州瑞博生物技术股份有限公司 一种药物组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675430B (zh) * 2005-08-12 2014-08-27 上海贺普药业股份有限公司 乙型肝炎病毒表面l蛋白相关肽
WO2009092396A1 (en) * 2008-01-25 2009-07-30 Universitätsklinikum Heidelberg Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as hbv and hdv entry inhibitors
CN107106686B (zh) * 2014-10-07 2022-09-27 Myr有限公司 Hbv和hdv感染的联合治疗
CN109718364A (zh) * 2017-10-27 2019-05-07 上海贺普药业股份有限公司 充分剂量条件下治疗乙肝病毒相关肝病的药物和方法
CN114828852A (zh) * 2019-12-24 2022-07-29 豪夫迈·罗氏有限公司 用于治疗hbv的靶向hbv的抗病毒药剂和/或免疫调节剂的药物组合
EP3865489A1 (en) * 2020-02-11 2021-08-18 Promidis S.r.l. Spirocyclic inhibitors of hepatitis b virus

Similar Documents

Publication Publication Date Title
JP2025503152A5 (https=)
CL2026000356A1 (es) Material de empaque a base de papel metalizado multicapa
CL2026000301A1 (es) Aparato para introducir un medio en un precursor alimenticio
CL2025003802A1 (es) Composiciones de fluidos de inmersión con contaminantes.
CL2025003089A1 (es) Alimentación, afilado y clasificación automáticos de cuchillas de carpintería.
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR202022000931U2 (https=)
BY13174U (https=)
CN307045271S (https=)
CN307044271S (https=)
CN307044209S (https=)
CN307044356S (https=)
CN307045872S (https=)
CN307046183S (https=)
CN307046354S (https=)
CN307047693S (https=)
CN307049042S (https=)
BY23966C1 (https=)